Biomarker screening for head and neck cancer radiation therapy
Part of Cancer, Mouth & dental clinical trials.
This trial is looking for people with head and neck cancer who are about to start radiation therapy (possibly combined with other treatments). The goal is to find biomarkers that may help predict how well the treatment works or what side effects might occur.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have head and neck cancer confirmed by a biopsy.
- You plan to have radiation therapy (alone or with chemo, immunotherapy, or targeted therapy) as a treatment to cure your cancer.
- You are 18 years or older.
- Your cancer has not spread to other parts of the body.
- You have not had radiation to the head or neck before.
- You do not have severe dry mouth or advanced heart, kidney, or liver failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This trial compares two treatments—a salivary gland procedure (sialendoscopy) and a light therapy (photobiomodulation)—to prevent dry mouth caused by radiation therapy for head and neck cancer. If you are about to start radiation and meet the dose limits, you may be eligible.
This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.
This study tests whether a newer radiation therapy technique, using non-coplanar beams, can reduce side effects like dry mouth and throat pain in people with mouth or throat cancer. You may be able to join if you are getting radiation therapy to both sides of the neck and have not had surgery for this cancer.
This Phase 1 study tests whether a citrus-flavored supplement (d-limonene gelcaps) can help prevent or reduce dry mouth (xerostomia) in people getting radiation plus chemotherapy for certain head and neck cancers. It aims to see how well the approach is tolerated and whether it can protect saliva function during treatment.
This trial tests an oral (mouth) care program for people with head and neck cancer who are about to start full-dose, curative radiation. It may help protect your mouth and salivary glands during treatment.
Hear when a new Xerostomia Due to Radiotherapy (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.